Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Research Area
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
SU11274 is a potent, selective, ATP-competitive inhibitor of c-Met (IC50 = 20 nM).1 It has much less or no activity against other receptor tyrosine kinases.1 SU11274 induces apoptosis and cell cycle arrest in transformed Ba/F3 cells and cancer cell lines.1,2
WARNING This product is not for human or veterinary use.
1. A novel small molecule Met inhibitor induces apoptosis in cells transformed by the oncogenic TPR-
2. The MET receptor tyrosine kinase is a potential novel therapeutic target for head and neck squamous cell carcinoma. Cancer Res. 69(7), 3021-3031 (2009).